Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,533 | 16,438 | 26,243 | 19,167 | 9,595 |
| Marketable Securities | 75,748 | 66,906 | 78,052 | 2,626 | 1,847 |
| Other current assets | 3,536 | 1,321 | 2,343 | 628 | 152 |
| TOTAL | $91,817 | $84,665 | $106,638 | $22,421 | $11,594 |
| Non-Current Assets | |||||
| PPE Net | 22,430 | 10,486 | 5,395 | 2,168 | 773 |
| Investments And Advances | 231 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,102 | 2,729 | 1,981 | 849 | 454 |
| TOTAL | $25,763 | $13,215 | $7,375 | $3,016 | $1,227 |
| Total Assets | $117,579 | $97,880 | $114,013 | $25,437 | $12,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,313 | 2,450 | 1,576 | 806 | 208 |
| Accrued Expenses | 333 | 0 | 324 | 170 | 69 |
| Other current liabilities | 833 | 1,103 | 1,006 | 833 | 0 |
| TOTAL | $13,078 | $4,556 | $3,302 | $1,810 | $277 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 0 | 0 | 1,554 | 3,866 | 5,036 |
| TOTAL | $6,113 | $6,170 | $4,471 | $4,520 | $5,036 |
| Total Liabilities | $19,191 | $10,727 | $7,773 | $6,330 | $5,314 |
| Shareholders' Equity | |||||
| Common Shares | 12 | 8 | 15 | 5 | 5 |
| Retained earnings | -70,443 | -30,559 | -11,447 | -6,979 | -3,681 |
| Other shareholders' equity | 6 | 6 | 0 | 6,943 | 6,935 |
| TOTAL | $98,388 | $87,153 | $106,240 | $19,108 | $7,507 |
| Total Liabilities And Equity | $117,579 | $97,880 | $114,013 | $25,438 | $12,820 |